02/16/22 Health Advisory: CDC Updated COVID-19 Vaccination Guidelines, and More.

Two hands wearing surgical gloves holding syringe and drawing from a vial

Requested Actions

  • For people who are moderately or severely immunocompromised:
    • People who have completed a primary series of an mRNA vaccine (Pfizer-BioNTech or Moderna) are recommended to receive an mRNA booster dose 3 months (instead of 5 months) after the last primary dose.
    • People who have received a single Johnson & Johnson’s Janssen COVID-19 vaccine should receive one additional dose of an mRNA COVID-19 vaccine and one booster dose (preferably mRNA) for a total of 3 vaccine doses.
    • Clarification that people who have completed their primary series of 3 mRNA doses should receive an mRNA vaccine booster dose—to make a total of 4 doses.
  • For those who previously received passive COVID-19 antibody products:
    • Simplification that people do not need to wait for any period prior to COVID-19 vaccination.
  • Strongly recommend patients get vaccinated. You are patients’ most trusted source of vaccine information.
  • Be aware, the US Food and Drug Administration postponed their advisory committee meeting to give more time to review available evidence on 3 doses of COVID-19 vaccine for children 6 months to 4 years.
  • Increase access to COVID-19 therapeutics. Enroll to become a provider by emailing mcm@doh.wa.gov or prescribe patients available products. You can find:

COVID-19 Vaccine

COVID-19 Testing

COVID-19 Test Processing

Labs report varying amounts of time to process COVID-19 tests. To support faster turnaround, we encourage providers to use in-state labs. The table below shows COVID-19 test processing times for in-state private labs.

FidaLab 24 to 30 hours 5,000
Kaiser 24 hours 700 to 800
LabCorp 24 to 48 hours Unknown
Northwest Pathology 48 to 72 hours 20,000
Quest 24 to 48 hours 700
UW Virology 24 to 48 hours 10,000 to 11,000
Atlas Genomic 24 to 48 hours 10,000

COVID-19 Therapeutics

  • Department of Health and Human Services (HHS) allocates monoclonal antibody and oral antiviral supplies to each state. DOH distributes doses to enrolled providers. Providers must enroll in Healthcare Partner Ordering Portal (HPoP) to manage COVID-19 therapeutics. Email mcm@doh.wa.gov to register for HPoP training, held Tuesdays at 9 a.m.
  • Once enrolled, to request a supply of monoclonal antibodies or therapeutics, complete a smart sheet.
  • Supplies of all therapies are current limited. Safeway, Haggen and independent pharmacies may have oral antivirals. Hospital-associated systems and infusion centers may have monoclonal antibodies. All therapies must be dispensed by prescription. Prescriptions for oral antivirals should include the appropriate dates of use to ensure initiation within a 5-day window. Oral therapies from Safeway are intended to be delivered to patients’ homes. Patients with questions about accessing their medication should call the pharmacy.
  • You can find:

Share with Patients:

Additional Resources

We ask that you notify us of patients being tested who are hospitalized or have contact with a confirmed case, and not wait for the lab confirmation. Fax the COVID-19 Report Form to 360-778-6103. You can leave us a non-urgent confidential report on our 24-hour Communicable Disease Report Line, 360-778-6150.

Contacting the Health Department

360-778-6100    Main Call Line – available M-F 8:30am to 4:30pm

360-715-2588    Afterhours Answering Service – available after 4:30pm and weekends

360-778-6150    Communicable Disease Report Line – 24 hours a day 7 days a week

360-778-6103    Confidential Communicable Disease Fax – 24 hours a day 7 days a week

1500 N State Street, Bellingham WA 98225